Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Aug-23 5:29 PM View:  | Carlson Capital L P 10% Owner | Tff Pharmaceuticals, Inc. (TFFP) | 16-Aug-23 | Sale | 1,000 | $0.39 | $391.60 | (< 1%) 10.13M to 10.13M | |
| 15-Aug-23 8:00 AM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 40,000 | $0.25 | $10,000.00 | 250% 15.98K to 55.98K | |
| 15-Aug-23 8:00 AM View: | Rocamboli Stephen Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 20,000 | $0.25 | $5,000.00 | 125% 16.0K to 36.0K | |
| 15-Aug-23 8:00 AM View: | Coleman Kirk Allen Chief Financial Officer | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 20,000 | $0.25 | $5,000.00 | 128% 15.68K to 35.67K | |
| 15-Aug-23 8:00 AM View: | Weisman Harlan F President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 600,000 | $0.25 | $150,000.00 | 280% 214.62K to 814.62K | |
| 15-Aug-23 8:00 AM View: | Mikhak Zamaneh Chief Medical Officer | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 120,000 | $0.25 | $30,000.00 | 800% 15.0K to 135.0K | |
| 15-Aug-23 8:00 AM View: | Roberts Brandi Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Private Purchase | 20,000 | $0.25 | $5,000.00 | 100% 0 to 20.0K | |
| 17-Aug-23 5:29 PM View: | Carlson Capital L P 10% Owner | Tff Pharmaceuticals, Inc. (TFFP) | 15-Aug-23 | Sale | 215,000 | $0.44 | $94,041.00 | (2%) 10.35M to 10.13M | |
| 13-Mar-23 8:00 AM View: | Coleman Kirk Allen Chief Financial Officer | Tff Pharmaceuticals, Inc. (TFFP) | 10-Mar-23 | Private Purchase | 12,000 | $0.79 | $9,457.20 | 327% 3.67K to 15.68K | |
| 13-Mar-23 8:00 AM View: | Weisman Harlan F President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 10-Mar-23 | Private Purchase | 150,000 | $0.88 | $131,835.00 | 232% 64.61K to 214.62K | |
| 13-Mar-23 8:00 AM View: | Mikhak Zamaneh Chief Medical Officer | Tff Pharmaceuticals, Inc. (TFFP) | 10-Mar-23 | Private Purchase | 15,000 | $0.82 | $12,300.00 | 100% 0 to 15.0K | |
| 13-Mar-23 4:22 PM View: | Rocamboli Stephen Director | Tff Pharmaceuticals, Inc. (TFFP) | 10-Mar-23 | Private Purchase | 13,000 | $0.80 | $10,432.50 | 433% 3.0K to 16.0K | |
| 19-Dec-22 8:00 AM View: | Weisman Harlan F President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Dec-22 | Private Purchase | 50,000 | $1.06 | $53,000.00 | 342% 14.62K to 64.61K | |
| 23-Nov-22 7:59 AM View: | Fletcher Aaron G.L. Director | Tff Pharmaceuticals, Inc. (TFFP) | 22-Nov-22 | Private Purchase | 43,470 | $1.15 | $49,990.50 | 6% 751.6K to 795.07K | |
| 30-Sep-22 5:20 PM View: | Thurman Randy H Director | Tff Pharmaceuticals, Inc. (TFFP) | 29-Sep-22 | Option Exercise | 40,255 | $2.50 | $100,638.00 | 100% 0 to 40.26K | |
| 30-Sep-22 5:20 PM View: | Thurman Randy H Director | Tff Pharmaceuticals, Inc. (TFFP) | 29-Sep-22 | Option Sale | 40,255 | $4.29 | $172,694.00 | (100%) 40.26K to 0 | |
| 20-May-22 5:17 PM View: | Weisman Harlan F Director | Tff Pharmaceuticals, Inc. (TFFP) | 20-May-22 | Purchase | 4,615 | $5.50 | $25,382.50 | 46% 10.0K to 14.62K | |
| 20-May-22 5:17 PM View: | Weisman Harlan F Director | Tff Pharmaceuticals, Inc. (TFFP) | 18-May-22 | Private Purchase | 2,500 | $5.12 | $12,800.00 | 33% 7.5K to 10.0K | |
| 17-May-22 9:57 PM View: | Fletcher Aaron G.L. Director | Tff Pharmaceuticals, Inc. (TFFP) | 17-May-22 | Purchase | 24,600 | $5.08 | $124,968.00 | 3% 727.0K to 751.6K | |
| 17-May-22 9:53 PM View: | Coleman Kirk Allen Chief Financial Officer | Tff Pharmaceuticals, Inc. (TFFP) | 17-May-22 | Purchase | 425 | $4.83 | $2,052.75 | 13% 3.25K to 3.67K | |
| 17-May-22 9:55 PM View: | Weisman Harlan F Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 2,500 | $4.74 | $11,850.00 | 50% 5.0K to 7.5K | |
| 17-May-22 9:51 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 16,000 | $4.78 | $76,480.00 | 59% 27.0K to 43.0K | |
| 17-May-22 9:57 PM View: | Fletcher Aaron G.L. Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 85,000 | $4.86 | $413,100.00 | 13% 642.0K to 727.0K | |
| 17-May-22 9:53 PM View: | Coleman Kirk Allen Chief Financial Officer | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 1,250 | $4.40 | $5,500.00 | 62% 2.0K to 3.25K | |
| 17-May-22 9:50 PM View: | Rocamboli Stephen Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-May-22 | Private Purchase | 3,000 | $4.54 | $13,620.00 | 19% 15.72K to 18.72K | |
| 04-Apr-22 6:34 PM View: | Fletcher Aaron G.L. Director | Tff Pharmaceuticals, Inc. (TFFP) | 04-Apr-22 | Private Purchase | 542,000 | $6.47 | $3,504,380.00 | 90% 600.0K to 1.14M | |
| 16-Sep-21 1:35 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-Sep-21 | Market Purchase | 10,000 | $7.10 | $71,000.00 | 59% 17.0K to 27.0K | 2% |
| 16-Sep-21 1:33 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 16-Sep-21 | Market Purchase | 1,000 | $7.30 | $7,300.00 | 100% 1.0K to 2.0K | (2%) |
| 19-May-21 4:05 PM View: | Fairbairn Malcolm Director | Tff Pharmaceuticals, Inc. (TFFP) | 19-May-21 | Market Purchase | 10,000 | $8.95 | $89,500.00 | < 1% 1.32M to 1.33M | 4% |
| 19-May-21 4:05 PM View: | Thurman Randy H Director | Tff Pharmaceuticals, Inc. (TFFP) | 18-May-21 | Market Purchase | 1,050 | $9.40 | $9,870.00 | 100% 0 to 1.05K | (1%) |
| 30-Mar-21 11:43 AM View: | Lung Therapeutics, Inc. 10% Owner | Tff Pharmaceuticals, Inc. (TFFP) | 26-Mar-21 | Market Sale | 715,000 | $14.00 | $10,010,000.00 | (24%) 2.95M to 2.23M | 5% |
| 17-Mar-21 8:00 PM View: | Rocamboli Stephen Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Option Exercise | 20,006 | $3.16 | $63,140.00 | 127% 15.72K to 35.73K | |
| 17-Mar-21 8:00 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Market Option Sale (Planned) | 5,000 | $17.05 | $85,250.00 | (83%) 6.0K to 1.0K | |
| 17-Mar-21 8:00 PM View: | Rocamboli Stephen Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Market Option Sale | 20,006 | $16.85 | $337,101.00 | (56%) 35.73K to 15.72K | |
| 17-Mar-21 8:00 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Option Exercise | 5,000 | $2.50 | $12,500.00 | 500% 1.0K to 6.0K | |
| 17-Mar-21 8:00 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Option Exercise | 50,000 | $2.50 | $125,000.00 | 500% 10.0K to 60.0K | |
| 17-Mar-21 8:00 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Mar-21 | Market Option Sale (Planned) | 50,000 | $17.04 | $852,000.00 | (83%) 60.0K to 10.0K | |
| 18-Feb-21 7:02 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-Feb-21 | Option Exercise | 40,000 | $2.50 | $100,000.00 | 400% 10.0K to 50.0K | |
| 18-Feb-21 7:02 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 16-Feb-21 | Market Option Sale (Planned) | 40,000 | $16.82 | $672,800.00 | (80%) 50.0K to 10.0K | |
| 18-Feb-21 7:02 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 16-Feb-21 | Market Option Sale (Planned) | 5,000 | $16.82 | $84,100.00 | (83%) 6.0K to 1.0K | |
| 18-Feb-21 7:02 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 16-Feb-21 | Option Exercise | 5,000 | $2.50 | $12,500.00 | 500% 1.0K to 6.0K | |
| 12-Feb-21 4:05 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 10-Feb-21 | Market Option Sale (Planned) | 700 | $20.16 | $14,112.00 | (4%) 16.68K to 15.98K | |
| 12-Feb-21 4:05 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 10-Feb-21 | Option Exercise | 700 | $2.50 | $1,750.00 | 4% 15.98K to 16.68K | |
| 20-Jan-21 8:37 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 20-Jan-21 | Market Option Sale (Planned) | 12,600 | $20.20 | $254,520.00 | (44%) 28.58K to 15.98K | |
| 20-Jan-21 8:37 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 20-Jan-21 | Option Exercise | 12,600 | $2.50 | $31,500.00 | 79% 15.98K to 28.58K | |
| 20-Jan-21 8:37 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 19-Jan-21 | Option Exercise | 55,100 | $2.50 | $137,750.00 | 345% 15.98K to 71.08K | |
| 20-Jan-21 8:37 PM View: | Mills Robert S Director | Tff Pharmaceuticals, Inc. (TFFP) | 19-Jan-21 | Market Option Sale (Planned) | 55,100 | $19.56 | $1,077,760.00 | (78%) 71.08K to 15.98K | |
| 20-Jan-21 8:37 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Jan-21 | Option Exercise | 40,000 | $2.50 | $100,000.00 | 235% 17.0K to 57.0K | |
| 20-Jan-21 8:37 PM View: | Mattes Glenn R. President and CEO Director | Tff Pharmaceuticals, Inc. (TFFP) | 15-Jan-21 | Market Sale (Planned) | 3,000 | $17.51 | $52,530.00 | (15%) 20.0K to 17.0K | |
| 20-Jan-21 8:36 PM View: | Coleman Kirk Allen CFO, Secretary and Treasurer | Tff Pharmaceuticals, Inc. (TFFP) | 15-Jan-21 | Market Option Sale (Planned) | 5,000 | $17.50 | $87,500.00 | (83%) 6.0K to 1.0K |
